Alderley Park-headquartered drug developer Redx Pharma has appointed a new chief financial officer.
Dr James Mead – who will also become an executive director of the board – is to join the company on 1 February 2019, taking over from Dominic Jackson who has served as interim chief financial officer since 3 November 2017.
Read the article in full at InsiderMedia.com